No Significant Benefit, But Ample Undesirable Effects The authors underscore that levothyroxine has been shown time and again to offer no significant benefit to patients with subclinical hypothyroidism of any type, emphasized in a 2018 meta-analysis of 21 randomized controlled trials, as reported by Medscape Medical News.